In 2019, Clark et al. used proteogenomic analysis to classify ccRCC into four immune subtypes: CD8+ inflamed, CD8- inflamed, VEGF immune-desert, and metabolic immune-desert (Clark et al., 2019). The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.